Clinical Trial Update: Retrospective Review of DTG/3TC Versus BIC/F/TAF Across a Multi Clinic Infectious Disease Organization in Southeast United States

View source ↗

Summary

Retrospective, multi-site comparison of dolutegravir/lamivudine (DTG/3TC) versus bictegravir/emtricitabine/tenofovir alafenamide (BIC/F/TAF) in HIV infection. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• BIC/F/TAF (bictegravir/emtricitabine/tenofovir alafenamide)
• DTG/3TC (dolutegravir/lamivudine)

Snippet

Sponsor: Midway Specialty Care Center | Conditions: Hiv, HIV-1-infection | Status: COMPLETED